Oncolytics Biotech Inc. (ONCY)
Chart Events
Performance Outlook
| Previous Close | 1.2100 |
| Open | 1.2400 |
| Bid | 1.2400 x 1400 |
| Ask | 1.2500 x 900 |
| Day's Range | 1.2100 - 1.2500 |
| 52 Week Range | 0.8000 - 2.2800 |
| Volume | |
| Avg. Volume | 214,365 |
| Market Cap | 74.603M |
| Beta (5Y Monthly) | 1.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4560 |
| Earnings Date | May 03, 2023 - May 08, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.00 |
- Insider Monkey
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2022 Earnings Call Transcript
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2022 Earnings Call Transcript March 3, 2023 Operator: Welcome to Oncolytics Biotech’s Fourth Quarter and Full Year 2022 Conference Call. Please be advised that this call is being recorded at the company’s request. I would now like to turn the call over to Jon Patton, Director of Investor Relations and […]
- PR Newswire
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced recent operational highlights and financial results for the fourth quarter and full year ended December 31, 2022. All dollar amounts are expressed in Canadian currency unless otherwise noted.
- CNW Group
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Friday, March 3, 2023, at 8:30 a.m. ET to discuss a corporate update and financial results for the fourth quarter and full year 2022.
